Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021). The biological and clinical significance of emerging SARS-CoV-2 variants. Nature Reviews Genetics, 1–17. https://doi.org/10.1038/s41576-021-00408-x

CNN, A. S. (n.d.). Pfizer begins Phase 2 and 3 trial of Covid-19 antiviral Paxlovid in children ages 6 to 17. CNN. Retrieved 22 March 2022, from https://www.cnn.com/2022/03/09/health/pfizer-paxlovid-pediatric-trial/index.html

Tong-Hyung, K. (n.d.). South Korea gets first supply of Pfizer’s COVID-19 pills. Retrieved January 20, 2022, from https://medicalxpress.com/news/2022-01-south-korea-pfizer-covid-pills.html

Jabagi, M. J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M., & Dray-Spira, R. (2021). Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older. JAMA. https://doi.org/10.1001/jama.2021.21699

Gurdasani, D., Bhatt, S., Costello, A., Denaxas, S., Flaxman, S., Greenhalgh, T., Griffin, S., Hyde, Z., Katzourakis, A., McKee, M., Michie, S., Ratmann, O., Reicher, S., Scally, G., Tomlinson, C., Yates, C., Ziauddeen, H., & Pagel, C. (2021). Vaccinating adolescents against SARS-CoV-2 in England: A risk–benefit analysis. Journal of the Royal Society of Medicine, 01410768211052589. https://doi.org/10.1177/01410768211052589

Abbas-Hanif, A., Modi, N., Smith, S. K., & Majeed, A. (2021). Covid-19 treatments and vaccines must be evaluated in pregnancy. BMJ, n2377. https://doi.org/10.1136/bmj.n2377

Clover’s COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest—Clover Biopharmaceuticals. (n.d.). Retrieved 4 October 2021, from https://www.cloverbiopharma.com/news/83.html

Here’s Where That COVID-19 Vaccine Infertility Myth Came From—And Why It Is Not True. (n.d.). Retrieved June 18, 2021, from https://www.henryford.com/blog/2021/04/fertility-rumor-covid-vaccine

Stoddard, J., Reynolds, E. K., Paris, R., Haller, S., Johnson, S., Zik, J., Elliote, E., Maru, M., Jaffe, A., Mallidi, A., Smith, A., Hernandez, R. G., Volk, H. E., Brotman, M. A., & Kaufman, J. (2021). The Coronavirus Impact Scale: Construction, Validation, and Comparisons in Diverse Clinical Samples [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/kz4pg

Fisman, D., Greer, A. L., & Tuite, A. (2020). Derivation and Validation of Clinical Prediction Rule for COVID-19 Mortality in Ontario, Canada. MedRxiv, 2020.06.21.20136929. https://doi.org/10.1101/2020.06.21.20136929

Chastain, D. B., Osae, S. P., Henao-Martínez, A. F., Franco-Paredes, C., Chastain, J. S., & Young, H. N. (2020). Racial Disproportionality in Covid Clinical Trials. New England Journal of Medicine. https://doi.org/10.1056/NEJMp2021971

Wang, C. J., Ng, C. Y., & Brook, R. H. (2020). Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing. JAMA, 323(14), 1341. https://doi.org/10.1001/jama.2020.3151

Wise, J. (2021). Covid-19: Extra 1.7 million people in England are asked to shield. BMJ, 372, n467. https://doi.org/10.1136/bmj.n467

Mori, Makoto, Harlan M. Krumholz, and Heather G. Allore. ‘Using Latent Class Analysis to Identify Hidden Clinical Phenotypes’. JAMA 324, no. 7 (18 August 2020): 700–701. https://doi.org/10.1001/jama.2020.2278.

🔥 Your COVID Roundup, Week #31. (n.d.). Retrieved December 9, 2020, from https://mailchi.mp/8338eb3924db/your-covid-roundup-7106445?e=feb8bf1ac8

Thomas, K., & Rabin, R. C. (2020, October 4). Trump’s Treatment Suggests Severe Covid-19, Medical Experts Say. The New York Times. https://www.nytimes.com/2020/10/04/health/trump-covid-treatment.html

Knight, S. R., Ho, A., Pius, R., Buchan, I., Carson, G., Drake, T. M., Dunning, J., Fairfield, C. J., Gamble, C., Green, C. A., Gupta, R., Halpin, S., Hardwick, H. E., Holden, K. A., Horby, P. W., Jackson, C., Mclean, K. A., Merson, L., Nguyen-Van-Tam, J. S., … Harrison, E. M. (2020). Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Development and validation of the 4C Mortality Score. BMJ, 370. https://doi.org/10.1136/bmj.m3339

Covid-19 Medical Risk Assessment – Alama. (n.d.). Retrieved October 2, 2020, from https://alama.org.uk/covid-19-medical-risk-assessment/

Kouzy, R., Jaoude, J. A., Garcia, C. J. G., Alam, M. B. E., Taniguchi, C. M., & Ludmir, E. B. (2020). Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic. JAMA Network Open, 3(7), e2015100–e2015100. https://doi.org/10.1001/jamanetworkopen.2020.15100

Awasthi, P. (n.d.). Scientists find five blood molecules linked to severe Covid-19 outcome in patients. @businessline. Retrieved August 20, 2020, from https://www.thehindubusinessline.com/news/science/scientists-find-five-blood-molecules-linked-to-severe-covid-19-outcome-in-patients/article32302700.ece

Manski, C. F. (2020). Bounding the Predictive Values of COVID-19 Antibody Tests (Working Paper No. 27226; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27226

Salvatore, C. M., Han, J.-Y., Acker, K. P., Tiwari, P., Jin, J., Brandler, M., Cangemi, C., Gordon, L., Parow, A., DiPace, J., & DeLaMora, P. (2020). Neonatal management and outcomes during the COVID-19 pandemic: An observation cohort study. The Lancet Child & Adolescent Health, 0(0). https://doi.org/10.1016/S2352-4642(20)30235-2

Horton, Richard. ‘Offline: COVID-19 and the Dangers of Sinophobia’. The Lancet 396, no. 10245 (18 July 2020): 154. https://doi.org/10.1016/S0140-6736(20)31600-7.

Huitfeldt, A. (2016). Is caviar a risk factor for being a millionaire? BMJ, 355. https://doi.org/10.1136/bmj.i6536

Oxford leads development of risk prediction model for more tailored COVID-19 shielding advice | University of Oxford. (n.d.). Retrieved 23 June 2020, from http://www.ox.ac.uk/news/2020-06-22-oxford-leads-development-risk-prediction-model-more-tailored-covid-19-shielding

Coggon, D., Croft, P., Cullinan, P., & Williams, A. (2020). ASSESSMENT OF WORKERS PERSONAL VULNERABILITY TO COVID-19 USING COVID-AGE. MedRxiv, 2020.05.21.20108969. https://doi.org/10.1101/2020.05.21.20108969

Sbidian, E., Josse, J., Lemaitre, G., Mayer, I., Bernaux, M., Gramfort, A., Lapidus, N., Paris, N., Neuraz, A., Lerner, I., Garcelon, N., Rance, B., Grisel, O., Moreau, T., Bellamine, A., Wolkenstein, P., Varoquaux, G., Caumes, E., Lavielle, M., … Audureau, E. (2020). Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: A cohort study of 4,642 in-patients in France. MedRxiv, 2020.06.16.20132597. https://doi.org/10.1101/2020.06.16.20132597

Cheng, H.-Y., Jian, S.-W., Liu, D.-P., Ng, T.-C., Huang, W.-T., Lin, H.-H., & for the Taiwan COVID-19 Outbreak Investigation Team. (2020). Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2020.2020